Regeneron's Evkeeza Approved For Ultra-Rare Genetic High Cholesterol – And Priced To Match

 
• By Jessica Merrill
  
Black Swan Event
Regeneron's Evkeeza is approved for an ultra-rare disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip